Management of deep infection of total hip replacement.
Exchange operation is recommended as the treatment of choice for most deep infections involving a total hip replacement. This revision arthroplasty comprises, in one stage, excision of soft tissue, removal of implant and cement, replacement with an appropriate implant using Palacos R acrylic cement loaded with an appropriate antibiotic and, more recently, systemic antibiotics. During our first 10 years without systemic antibiotics we have achieved an overall 77 per cent success rate from a first attempt in 583 patients and a 90 per cent success rate after subsequent exchange procedures. Morbidity is significant but acceptable. Success is defined as control of infection, no loosening, and useful function. The factors associated with failures include, in particular, specific infections (Pseudomonas group, Streptococcus group D, Proteus group, and Escherichia coli), delay in operation and inadequate antibiotic dosage in the cement.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000517:prevention & control / Q000628:therapy*; D001843:Bone Cements; D004927:Escherichia coli Infections / Q000628:therapy; D006622:Hip Prosthesis; D006801:Humans; D008722:Methods; D011183:Postoperative Complications / Q000628:therapy*; D011512:Proteus Infections / Q000628:therapy; D011552:Pseudomonas Infections / Q000628:therapy; D013290:Streptococcal Infections / Q000628:therapy
D000900:Anti-Bacterial Agents; D001843:Bone Cements